tradingkey.logo

STAAR Surgical Co

STAA
27.400USD
-0.010-0.04%
Fechamento 11/11, 16:00ETCotações atrasadas em 15 min
1.35BValor de mercado
PerdaP/L TTM

STAAR Surgical Co

27.400
-0.010-0.04%

Mais detalhes de STAAR Surgical Co Empresa

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Informações de STAAR Surgical Co

Código da empresaSTAA
Nome da EmpresaSTAAR Surgical Co
Data de listagemFeb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
Número de funcionários1157
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 24
Endereço1911 Walker Ave
CidadeMONROVIA
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal91016
Telefone16263037902
Sitehttps://www.staar.com/
Código da empresaSTAA
Data de listagemFeb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA

Executivos da empresa STAAR Surgical Co

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
25.57K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
25.57K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Others
18.18M
41.02%
Japan
10.91M
24.63%
U. S.
5.63M
12.71%
China
5.30M
11.96%
South Korea
4.29M
9.69%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: ter, 11 de nov
Atualizado em: ter, 11 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Broadwood Capital, Inc.
27.18%
BlackRock Institutional Trust Company, N.A.
13.50%
The Vanguard Group, Inc.
8.56%
Armistice Capital LLC
5.65%
Yunqi Capital Limited
5.03%
Outro
40.08%
Investidores
Investidores
Proporção
Broadwood Capital, Inc.
27.18%
BlackRock Institutional Trust Company, N.A.
13.50%
The Vanguard Group, Inc.
8.56%
Armistice Capital LLC
5.65%
Yunqi Capital Limited
5.03%
Outro
40.08%
Tipos de investidores
Investidores
Proporção
Hedge Fund
44.85%
Investment Advisor
32.99%
Investment Advisor/Hedge Fund
13.54%
Research Firm
5.07%
Pension Fund
1.07%
Bank and Trust
0.58%
Individual Investor
0.46%
Venture Capital
0.08%
Insurance Company
0.04%
Outro
1.31%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Broadwood Capital, Inc.
13.52M
27.39%
--
--
Sep 24, 2025
BlackRock Institutional Trust Company, N.A.
6.72M
13.61%
-298.81K
-4.26%
Jun 30, 2025
The Vanguard Group, Inc.
4.38M
8.88%
-1.02M
-18.96%
Jun 30, 2025
Armistice Capital LLC
2.81M
5.7%
-188.00K
-6.27%
Jun 30, 2025
Yunqi Capital Limited
2.50M
5.07%
+88.77K
+3.68%
Sep 19, 2025
State Street Investment Management (US)
2.00M
4.06%
+7.97K
+0.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.19M
2.42%
+3.33K
+0.28%
Jun 30, 2025
BofA Global Research (US)
1.15M
2.32%
+193.56K
+20.30%
Jun 30, 2025
Morgan Stanley & Co. LLC
873.98K
1.77%
+393.30K
+81.82%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
AltShares Event-Driven ETF
3.35%
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.37%
SPDR S&P Health Care Equipment ETF
1.59%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.85%
Royce Quant Small-Cap Quality Value ETF
0.3%
SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
SPDR S&P 600 Small Cap Growth ETF
0.1%
Ver Mais
AltShares Event-Driven ETF
Proporção3.35%
AltShares Merger Arbitrage ETF
Proporção2.71%
ProShares Merger ETF
Proporção2.37%
SPDR S&P Health Care Equipment ETF
Proporção1.59%
NYLI Merger Arbitrage ETF
Proporção0.87%
Invesco S&P SmallCap Health Care ETF
Proporção0.85%
Royce Quant Small-Cap Quality Value ETF
Proporção0.3%
SPDR S&P SmallCap 600 ESG ETF
Proporção0.13%
iShares S&P Small-Cap 600 Growth ETF
Proporção0.1%
SPDR S&P 600 Small Cap Growth ETF
Proporção0.1%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI